Dr. Xi Wang obtained Bachelor of Science from Tsinghua University and Ph.D. degree from Cornell University. Dr. Wang was mentored by Dr. Scott A. Armstrong and was trained in two top cancer research institutes - Memorial Sloan Kettering Cancer Center and Dana Farber Cancer Institute/Harvard Medical School. Her PhD thesis focused on the genetic and epigenetic regulation in cancer. Dr. Wang has worked as a Computational Biologist/Senior Scientist at Agios Pharmaceuticals and Merck Research Laboratories at Boston. Her work focused on oncology drug discovery, drug mechanisms of action and biomarker identification using genomics and bioinformatics approaches.

王曦本科毕业于清华大学生命科学与技术系，博士毕业于美国康奈尔大学（Cornell University），师从于著名白血病专家，美国国家医学科学院院士Scott Armstrong博士。王博士曾在两所世界顶级癌症研究中心（Memorial Sloan Kettering Cancer Center, Dana Farber Cancer Institute/Harvard Medical School）接受科研训练。先后在波士顿肿瘤代谢公司Agios Pharmaceuticals和著名医药公司默克（MSD）工作，历任研究科学家、资深科学家。王曦博士运用基因组学和生物信息学的方法来帮助癌症药物研发， 包括寻找新的药物靶点和适应症，理解药物机理和抗药性等等。

wangxi@westlake.edu.cn